Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
9447135
Publication Date
9-20-2016
Abstract
Mithramycin derivatives and their pharmaceutically acceptable salts are disclosed. The mithramycin derivatives can be used in the treatment of Ewing sarcoma or other cancer or neuro-disease associated with an aberrant erythroblast transformation- specific transcription factor.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
14/717,542
Filing Date
05/20/2015
Recommended Citation
Rohr, Jürgen; Scott, Daniel; Leggas, Markos; Chen, Jhong-Min; and Tsodikov, Oleg V., "Semi-Synthetic Mithramycin Derivatives with Anti-Cancer Activity" (2016). Pharmaceutical Sciences Faculty Patents. 160.
https://uknowledge.uky.edu/ps_patents/160
